We invite anyone with an interest in glomerular kidney disease to join us and participate in any or all of the activities.
We believe that only through a large scale collaboration among clinicians, academic scientists, and biotech companies an impact can be made in diagnosis and treatment of glomerular disease. Tremendous advances have been made in the field of glomerular disease. Nevertheless, the therapeutic management of glomerular disease often feels like “witchcraft” rather than evidence based medicine. This is fueling deep frustrations and is fueling our motivation for a Glomerular Disease Study & Trial Consortium.